Changeflow GovPing Healthcare & Life Sciences Medici Intent to Use Trademark - Cancer Treatments
Routine Notice Added Final

Medici Intent to Use Trademark - Cancer Treatments

Favicon for changeflow.com USPTO Trademarks - Pharmaceuticals (Class 005)
Published
Detected
Email

Summary

The USPTO received a trademark application for "MEDICI" (Serial No. TM98956738) filed by Medici Therapeutics on January 13, 2025. The application covers pharmaceutical preparations for the treatment of cancer, immune system disorders, and related conditions under an Intent-to-Use basis.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

Medici Therapeutics filed a trademark application with the USPTO for "MEDICI" (Serial No. TM98956738) on January 13, 2025. The application covers pharmaceutical preparations for the treatment of cancer, immune system disorders, and related conditions, filed under Intent-to-Use provisions.

This is a routine trademark filing notice with no new compliance obligations or deadlines. No immediate regulatory action is required from other parties. Competitors or stakeholders in the pharmaceutical space may wish to conduct clearance searches if considering similar trademarks in Class 5.

Archived snapshot

Apr 1, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

MEDICI

Intent to Use TM98956738 Kind: intenttouse Mar 31, 2026

Abstract

Pharmaceutical preparations for the treatment of cancer, immune system disorders, and related conditions

Filing Date

2025-01-13

View original document →

Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
January 13th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Trademark Filing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!